RadNet

RadNet EBITDA Margin

The EBITDA Margin of RadNet (RDNT) as of Oct 6, 2026 is 4.45 %. In the previous year, EBITDA Margin was 13.25 % — a change of -66.41% (lower).

EBITDA Margin

4.45 %

YoY

-66.41%

Last updated:

EBITDA Margin of RadNet is 2026 4.45 % . EBITDA Margin of RadNet was 2025 13.25 % . It decreases by -66.41% lower compared to the previous year.

The RadNet EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
15.10 USD
Jan 1, 2019
13.04 USD
Jan 1, 2020
11.43 USD
Jan 1, 2021
13.63 USD
Jan 1, 2022
11.35 USD
Jan 1, 2023
14.05 USD
Jan 1, 2024
13.25 USD
Jan 1, 2025
4.45 USD
The RadNet EBITDA Margin history
YEAREBITDA MarginYoY
4.45 %-66.41%
13.25 %-5.66%
14.05 %+23.80%
11.35 %-16.76%
13.63 %+19.28%
11.43 %-12.35%
13.04 %-13.65%
15.10 %+19.17%
12.67 %+6.66%
11.88 %-3.55%
12.32 %-21.51%
15.69 %—
Access this data via the Eulerpool API

RadNet Stock analysis

What does RadNet do? RadNet Inc is a leading company in the field of diagnostic imaging in the United States. The company was founded in 1985 and has since undergone impressive development. Today, RadNet operates the largest network of diagnostic imaging centers in the United States and offers a comprehensive range of diagnostic and therapeutic procedures. RadNet's business model is focused on providing high-quality diagnostic imaging services at competitive prices. The company generates most of its revenue by providing imaging services to Medicare patients and private patients funded by insurers and employers. RadNet also offers its services directly to healthcare facilities, including physician practices, hospitals, and clinics. RadNet offers a wide range of diagnostic imaging services, including X-rays, CT scans, MRI scans, and nuclear medicine procedures. The company also offers specialized imaging services, including mammography, ultrasound, and PET-CT. RadNet, along with its partners, also provides radiation therapy and other cancer treatments. In recent years, RadNet has also experienced strong development in the field of telemedicine and artificial intelligence (AI). An AI-based image processing platform has been developed to assist in the detection of cancer and other diseases. The platform uses innovative algorithms to read and analyze imaging results faster and more accurately. The company has also conducted a series of acquisitions in recent years to strengthen its position in the field of diagnostic imaging. In 2017, the company acquired Doshi Diagnostics Imaging Services, which operated in New York City. In 2018, the company entered into a long-term partnership with Florida-based Diagnostic Centers of America (DCA), and in 2020, the company acquired Elite Imaging of South Florida LLC. These acquisitions have helped RadNet strengthen its presence in core markets and expand its reach into new areas. RadNet has also made a name for itself by developing innovative technology and new models of collaboration. The company has a firm place in the healthcare and research world, working together with respected health systems, academies, and universities to find new ways to diagnose and treat diseases. In summary, RadNet Inc is a leading company in the field of diagnostic imaging. The company offers high-quality and innovative services tailored to the needs of patients, physicians, and healthcare facilities. RadNet remains committed to achieving the best possible outcomes for its customers and further expanding its position in the market. RadNet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RadNet stock

EBITDA Margin of RadNet is 4.45 % in 2026.

EBITDA Margin of RadNet changed from 13.25 % to 4.45 %, representing a -66.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin RadNet since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's RadNet with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

Margins — RadNet

All Key Metrics — RadNet